MENUNews and Events
Recent Releases
05/06/2024 - 1:30pm
Haymart gets $3.3M to develop risk-based approach to thyroid cancer survivorship care
Do all thyroid cancer survivors need the same level of follow-up care and monitoring? With a new $3.3 million grant from the National Cancer Institute, Megan Haymart, M.D., will identify survivors at different risks of recurrence and develop a system for long-term monitoring based on that risk.
04/29/2024 - 4:00pm
With $5M grant, Rogel team will conduct preclinical work to develop drugs targeting cancer master regulator
University of Michigan Rogel Cancer Center researcher Arul Chinnaiyan, M.D., Ph.D., has received a $5 million grant from the J.C. Kennedy Foundation to conduct laboratory tests of a potential drug candidate targeting a master regulator that controls the majority of genes involved in the most challenging type of prostate cancer.
04/11/2024 - 4:15pm
Zhou gets $2.9M to develop a system to predict outcomes in multiple myeloma
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It’s a cancer that’s considered incurable, with survival ranging from less than a year to more than a decade, depending on the extent and aggressiveness of the tumors.
04/10/2024 - 3:45pm
AACR 2024: Rogel Recap of the 2024 AACR Annual Meeting
Highlights from Rogel's presence at the 2024 AACR Annual Meeting
04/10/2024 - 2:00pm
AACR 2024: NextGen Star Abhijit Parolia presents on new protein that drives prostate cancer progression
Abhijit Parolia, M.S., Ph.D., assistant professor of pathology and urology at the University of Michigan Health Rogel Cancer Center, was named at NextGen Star by the American Association of Cancer Research.
Publications
